Literature DB >> 3389180

Psychiatric disturbances associated with myasthenia gravis.

G Magni1, G F Micaglio, R Lalli, L Bejato, M R Candeago, H Merskey, C Angelini.   

Abstract

Seventy-four myasthenic patients (54 F, 20 M; mean age 49.6 years) were evaluated using the diagnostic criteria of the DSM-III in order to investigate the prevalence of psychiatric disturbances in this order. Fifty-one had had thymectomies, of whom 28 females had hyperplasia, two females and five males had involution of the thymus, and 10 females and six males had thymomata. Psychiatric disturbances were observed in 38 subjects (51%), in particular, adjustment disorders with depressed mood and mixed emotional features (19%) (22% including adjustment disorder with anxious mood), affective disorders (13.5%) and personality disorders (18%).

Entities:  

Mesh:

Year:  1988        PMID: 3389180     DOI: 10.1111/j.1600-0447.1988.tb05148.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  8 in total

Review 1.  Diagnosis and management of autoimmune myasthenia gravis.

Authors:  Corrado Angelini
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  The Relationship of Symptoms of Anxiety and Depression with Disease Severity and Treatment Modality in Myasthenia Gravis: A Cross-sectional Study.

Authors:  Fikret Aysal; Oğuz Karamustafalioğlu; Başak Özçelik; Meltem Yilmaz; Nesrin Karamustafalioğlu; Hüseyin Yumrukçal; Onur Tankaya
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

Review 3.  Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment.

Authors:  Isin Baral Kulaksizoglu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

4.  Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study.

Authors:  Yasushi Suzuki; Kimiaki Utsugisawa; Shigeaki Suzuki; Yuriko Nagane; Masayuki Masuda; Chiaki Kabasawa; Yuko Shimizu; Hiroya Utsumi; Shinichiro Uchiyama; Kazuo Fujihara; Norihiro Suzuki
Journal:  BMJ Open       Date:  2011-12-19       Impact factor: 2.692

5.  Fatigue in myasthenia gravis: risk factors and impact on quality of life.

Authors:  Sarah Hoffmann; Johanna Ramm; Ulrike Grittner; Siegfried Kohler; Jana Siedler; Andreas Meisel
Journal:  Brain Behav       Date:  2016-08-02       Impact factor: 2.708

6.  Prospective study of stress, depression and personality in myasthenia gravis relapses.

Authors:  Anca Bogdan; Carolina Barnett; Abdulrahman Ali; Mohammed AlQwaifly; Alon Abraham; Shabber Mannan; Eduardo Ng; Vera Bril
Journal:  BMC Neurol       Date:  2020-06-29       Impact factor: 2.474

7.  Prevalence and Associated Factors of Depressive Symptoms in Patients with Myasthenia Gravis: A Cross-Sectional Study of Two Tertiary Hospitals in Riyadh, Saudi Arabia.

Authors:  Mohammed H Alanazy
Journal:  Behav Neurol       Date:  2019-09-15       Impact factor: 3.342

8.  Comorbid Depressive and Anxiety Symptoms in a Patient with Myasthenia Gravis.

Authors:  Karthik R Cherukupally; Kodjovi Kodjo; Oluwaseun Ogunsakin; Olaniyi Olayinka; Patrice Fouron
Journal:  Case Rep Psychiatry       Date:  2020-01-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.